30 Day Notice

Federal Register / Vol. 82, No. 173 / Friday, September 8, 2017 / Notices
go/connectpro_overview. FDA has
verified the Web site addresses in this
document, as of the date this document
publishes in the Federal Register, but
Web sites are subject to change over
time.
Transcripts: Please be advised that as
soon as a transcript of the public
workshop is available, it will be
accessible at https://
www.regulations.gov. It may be viewed
at the Dockets Management Staff (see
ADDRESSES). A link to the transcript will
also be available on the Internet at
https://www.fda.gov/MedicalDevices/
NewsEvents/WorkshopsConferences/
default.htm.
IV. References
The following references are on
display in the Dockets Management
Staff (see ADDRESSES) and are available
for viewing by interested persons
between 9 a.m. and 4 p.m., Monday
through Friday; they are also available
electronically at https://
www.regulations.gov. FDA has verified
the Web site addresses, as of the date
this document publishes in the Federal
Register, but Web sites are subject to
change over time.
1. National Cancer Institute, ‘‘Cancer Stat
Facts: Cervix Uteri Cancer,’’ (http://
seer.cancer.gov/statfacts/html/
cervix.html).
2. Horner, M.J., S.F. Altekruse, Z. Zou, L.
Wideroff, et al. ‘‘U.S. Geographic
Distribution of Pre-Vaccine Era Cervical
Cancer Screening, Incidence, Stage, and
Mortality.’’ Cancer Epidemiology,
Biomarkers & Prevention. 2011 Jan.;
20(4):591–9. doi: 10.1158/1055–9965.
EPI–10–1183.
3. Freeman, H.W.B. ‘‘Excess Cervical Cancer
Mortality: A Marker for Low Access to
Health Care in Poor Communities.’’
Rockville (MD): National Cancer
Institute, Center to Reduce Cancer Health
Disparities; 2005.
Dated: September 1, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning,
Legislation, and Analysis.
BILLING CODE 4164–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

sradovich on DSK3GMQ082PROD with NOTICES

National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the NHLBI Special Emphasis
Panel.

17:18 Sep 07, 2017

Jkt 241001

Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Resources for Clinical Trials.
Date: September 20, 2017.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7200, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Michael P. Reilly, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7200, Bethesda, MD 20892, 301–827–7975,
reillymp@nhlbi.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 1, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–19027 Filed 9–7–17; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health

[FR Doc. 2017–19029 Filed 9–7–17; 8:45 am]

VerDate Sep<11>2014

The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

42559

would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Pancreatic
Cancer Detection Consortium (U01).
Date: November 3, 2017.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W240, Rockville, MD 20850, (Telephone
Conferece Call).
Contact Person: Hasan Siddiqui, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W240, Bethesda, MD
20892–9750, 240–276–5122, hasan.siddiqui@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Cooperative Agreement To Develop Targeted
Agents Used With Systemic Agents Plus
Radiotherapy.
Date: November 17, 2017.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W640, Rockville, MD 20850, (Telephone
Conferece Call).
Contact Person: Saejeong J. Kim, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W640, Bethesda, MD 20892–9750,
240–276–7684, saejeong.kim@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: September 1, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–19026 Filed 9–7–17; 8:45 am]

National Cancer Institute; Notice of
Closed Meetings

BILLING CODE 4140–01–P

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

PO 00000

Frm 00020

Fmt 4703

Sfmt 4703

National Institutes of Health
Proposed Collection; 30-Day Comment
Request; Application To Participate in
the National Institutes of Health
Technical Assistance Programs:
Commercialization Accelerator
Program (CAP)
AGENCY:

National Institutes of Health,

HHS.
ACTION:

E:\FR\FM\08SEN1.SGM

Notice.

08SEN1

42560

Federal Register / Vol. 82, No. 173 / Friday, September 8, 2017 / Notices

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below. This proposed
information collection was previously
published in the Federal Register on
June 15, 2017, page 27516 (82 FR 27516)
and allowed 60 days for public
comment. No public comments were
received. The purpose of this notice is
to allow an additional 30 days for public
comment.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:

Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, should be
directed to the: Office of Management
and Budget, Office of Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
ADDRESSES:

approval of the information collection
listed below.
Proposed Collection: Application to
Participate in the National Institutes of
Health Technical Assistance Programs:
Commercialization Accelerator Program
(CAP)—0925—Existing Without OMB
Approval, Office of Extramural
Programs (OEP)/Office of Extramural
Research (OER), Office of the Director
(OD)/National Institutes of Health.
Need and Use of Information
Collection: The purpose of this
application is to collect information to
be used internally by the NIH SBIR/
STTR staff to identify and select small
businesses that would most benefit if
selected as participants in the NIH
Commercialization Accelerator Program
(CAP). The data will not be used to
formulate or change policies. Rather, it
will be used to enable NIH SBIR/STTR
staff to be responsive to its constituents
by offering commercialization training
to meet the goals of the Phase II small
business NIH awardees. The form will
be online for any potential CAP
applicant companies and completed
electronically.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
150.

the data collection plans and
instruments, contact: J. P. Kim, NIH
SBIR/STTR Program Manager & NIH
Extramural Data Sharing Policy Officer,
Small Business Innovation Research
(SBIR) and Small Business Technology
Transfer (STTR) Program Office, Office
of Extramural Programs (OEP)/Office of
Extramural Research (OER), Office of
the Director (OD)/National Institutes of
Health (NIH), 6705 Rockledge Drive,
Suite 350; Bethesda, Maryland 20892–
7963 or call non-toll-free number (301)
435–0189 or Email your request,
including your address to: jpkim@
nih.gov. Formal requests for additional
plans and instruments must be
requested in writing.
SUPPLEMENTARY INFORMATION: The
Commercialization Accelerator Program
(CAP), National Institutes of Health,
may not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of respondent

Average time
per response

Total annual
burden hour

SBIR Phase II Awardees .................................................................................

100

1

90

150

Total ..........................................................................................................

100

100

........................

150

Dated: September 1, 2017.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.

ACTION:

[FR Doc. 2017–19078 Filed 9–7–17; 8:45 am]

SUMMARY:

BILLING CODE 4140–01–P

DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
sradovich on DSK3GMQ082PROD with NOTICES

Number of
responses per
respondent

[Docket No. USCG–2016–1084]

Navigation and Vessel Inspection
Circular (NVIC) 05–17; Guidelines for
Addressing Cyber Risks at Maritime
Transportation Security Act (MTSA)
Regulated Facilities
AGENCY:

Coast Guard, DHS.

VerDate Sep<11>2014

17:18 Sep 07, 2017

Jkt 241001

Notice of availability and
request for comments; extension of
comment period.
The Coast Guard is extending
the comment period for its notice of
availability and request for comments,
published on July 12, 2017. The notice
announced the availability of the draft
Navigation and Vessel Inspection
Circular (NVIC) 05–17 entitled
Guidelines for Addressing Cyber Risks
at Maritime Transportation Security Act
(MTSA) Regulated Facilities, and
requested public comments on the draft.
The comment period was set to close on
September 11, 2017. The Coast Guard
has received requests to extend the
comment period by 30 days due to the
conditions caused by hurricane Harvey,
which prevent some members of the
public from submitting comments by
the original deadline.

PO 00000

Frm 00021

Fmt 4703

Sfmt 4703

Comments and related material
must reach the Coast Guard on or before
October 11, 2017.

DATES:

You may submit comments
identified by docket number USCG–
2016–1084 using the Federal
eRulemaking Portal at http://
www.regulations.gov. See the ‘‘Public
Participation and Request for
Comments’’ portion of the
SUPPLEMENTARY INFORMATION section of
the July 12, 2017 notice for further
instructions on submitting comments.
ADDRESSES:

If
you have questions on this notice, call
or email, Jason Warren, Coast Guard;
telephone 202–372–1106, email
Jason.S.Warren@uscg.mil or LCDR
Josephine Long, Coast Guard; telephone
202–372–1109, email
Josephine.A.Long@uscg.mil.

FOR FURTHER INFORMATION CONTACT:

E:\FR\FM\08SEN1.SGM

08SEN1